Scarica l'app Stockscreener
8.2873
0.60%
-0.0727
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.36
Aprire:
$8.3
Volume 24 ore:
500.25K
Relative Volume:
0.13
Capitalizzazione di mercato:
$373.13M
Reddito:
$123.87M
Utile/perdita netta:
$62.49M
Rapporto P/E:
4.9639
EPS:
1.6695
Flusso di cassa netto:
$-87.53M
1 W Prestazione:
+0.61%
1M Prestazione:
+38.96%
6M Prestazione:
+147.32%
1 anno Prestazione:
+79.48%
Intervallo 1D:
$8.03
$8.40
Intervallo di 1 settimana:
$7.31
$8.50
Portata 52W:
$2.71
$8.85
Agenus Inc Stock (AGEN) Company Profile
Nome
Agenus Inc
Settore
Industria
Telefono
781-674-4410
Indirizzo
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
8.2899 | 337.12M | 123.87M | 62.49M | -87.53M | 1.6695 |
VRTX
Vertex Pharmaceuticals Inc
|
549.33 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
820.47 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,054.47 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
146.32 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
214.06 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-28 | Ripresa | H.C. Wainwright | Buy |
| 2022-09-28 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-04-22 | Iniziato | B. Riley FBR | Buy |
| 2016-10-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Reiterato | Maxim Group | Buy |
| 2016-03-11 | Aggiornamento | Maxim Group | Hold → Buy |
| 2015-12-16 | Iniziato | Jefferies | Buy |
| 2015-10-27 | Downgrade | Maxim Group | Buy → Hold |
| 2015-07-27 | Reiterato | MLV & Co | Buy |
| 2015-06-11 | Iniziato | Oppenheimer | Outperform |
| 2015-01-12 | Reiterato | Maxim Group | Buy |
| 2015-01-09 | Reiterato | MLV & Co | Buy |
| 2015-01-09 | Reiterato | Maxim Group | Buy |
| 2014-12-19 | Reiterato | Maxim Group | Buy |
| 2014-05-08 | Reiterato | Maxim Group | Buy |
| 2014-03-14 | Reiterato | MLV & Co | Buy |
| 2013-10-08 | Reiterato | Maxim Group | Buy |
| 2012-01-05 | Iniziato | William Blair | Outperform |
| 2011-12-01 | Iniziato | Global Hunter Securities | Buy |
Mostra tutto
Agenus Inc Borsa (AGEN) Ultime notizie
Agenus Inc (AGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
AGEN Stock TUESDAY MADNESS! (news Update) Agenus Stock Analysis Best Broker Review Challenge Cup Final 2026 (5MyfQl06Kh) - Mshale
Agenus Inc. (AGEN) Latest Stock News & Headlines - Yahoo Finance
Agenus extends $24.75 million loan maturity, adjusts payment terms with Ocean 1181 - Investing.com
Form 8K Agenus Inc For: 18 August By Investing.com - Investing.com South Africa
Agenus Extends $24.75M Term Loan to 2029 at 13% With Ocean 1181; Partly Payable in Stock - TradingView
Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock - Stock Titan
AGEN Q2 2026 Earnings: EPS Misses Estimates by 119.61% as Shares Slide 2.32%EBITDA Estimate Trend - Vinanet
Agenus Inc.AGEN Stock Chart Technical Analysis For 05-07-18 Monday Night Raw (hiEG5bsL6M) - Mshale
AGENUS INC SEC Filing (Aug 17, 2026) - Stock Titan
Agenus Puts Its BOT+BAL Cancer Combo To The Test - Finimize
Renaissance Technologies LLC Sells 257,900 Shares of Agenus Inc. $AGEN - MarketBeat
HC Wainwright Estimates Agenus' Q3 Earnings (NASDAQ:AGEN) - MarketBeat
Bold Move By Agenus: Cutting Costs By 60% To Focus On Groundbreaking Cancer Treatments Nikoloz Basilashvili (41VwNJliWR) - Mshale
Agenus grants CEO Garo Armen 1,971,500 performance-based stock options at $7.78 per share - Bitget
Agenus (NASDAQ: AGEN) awards 1.97M performance-tied stock options to CEO - Stock Titan
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL S - The National Law Review
Form 8K Agenus Inc For: 11 August By Investing.com - Investing.com South Africa
Agenus appoints Marco Tullio Marcucci to board of directors By Investing.com - Investing.com Nigeria
Agenus appoints Marco Tullio Marcucci to board of directors - Investing.com
Agenus Director Brian Corvese Granted 100,000 Stock Options Under 2019 Equity Incentive Plan - Kalkine Media
Agenus Director Thomas L. Harrison Granted 50,000 Stock Options Under 2019 Equity Incentive Plan - Kalkine Media
AGENUS appoints Marco Tullio Marcucci to its Board as Class II director - TradingView
Agenus Inc. (AGEN) expands board, appoints Marco Tullio Marcucci as Class II director - Stock Titan
Agenus Inc (AGEN) awards 50,000 stock options to director Thomas L. Harrison - Stock Titan
Agenus (AGEN) director Brian Corvese receives 100,000 stock options at $7.78 - Stock Titan
Wainwright cuts Agenus stock price target to $25 on higher costs - Investing.com Nigeria
Wainwright cuts Agenus stock price target to $25 on higher costs By Investing.com - Investing.com India
HC Wainwright Issues Positive Outlook for Agenus Earnings - MarketBeat
AGEN Stock (Agenus Stock) AGEN STOCK Analysis AGEN STOCK PREDICTION In AGEN Stock News Today Bella Vaughn Hunter Johnson Engagement (u90ZBraz9y) - Mshale
Why Agenus (AGEN Stock) Just Rocketed Up—Buy Now Or Too Late? Cigarette (l3DDhgoK4D) - Mshale
Agenus Inc (AGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agenus (AGEN) Stock Drops As One Off Gain Masks Profit Slip - Sahm
Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Agenus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agenus Files for Resale of Up to 78 Million Shares - marketscreener.com
Agenus: Q2 Earnings Snapshot - Yahoo Finance
AGENUS INC Q2 2026: Revenue $34.5M, EPS $0.96— 10-Q Summary - TradingView
Agenus (NASDAQ: AGEN) raises $85M and books Zydus gain but flags going concern risk - Stock Titan
Agenus Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Agenus (NASDAQ: AGEN) files S-3 for 77.9M share resale and warrant cash - Stock Titan
Agenus Inc. (AGEN) awards 50,000 stock options to director Wright - Stock Titan
AGENUS INC (AGEN) awards 100,000 stock options to its CMO - stocktitan.net
Agenus Inc (AGEN) Stock News Today - TradingKey
Agenus Inc. (AGEN) grants director 50,000 stock options at $7.78 - Stock Titan
Agenus (AGEN) awards 200,000 stock options to executive chair Jennifer Buell - Stock Titan
Agenus Advances BOT+BAL in Neoadjuvant MSS Colon Cancer Through Phase 3 ROBBIN Trial - Oncodaily
Agenus reports Q2 results, plans phase 3 colon cancer trial - Investing.com
Agenus reports Q2 results, plans phase 3 colon cancer trial By Investing.com - Investing.com Nigeria
Is Agenus Inc (AGEN) Overvalued After Q2 Earnings Beat? Q2 EPS: $0.06, Revenue: $34.5M; GF Score: 40/100 - GuruFocus
Form 8K Agenus Inc For: 6 August By Investing.com - Investing.com Canada
Agenus Inc Azioni (AGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):